or Try an Advanced Search...

    Technical Analysis for IMMP - Immutep Limited

    Grade Last Price % Change Price Change
    F 2.01 0.00% 0.00
    IMMP closed unchanged on Monday, July 1, 2024, on 70 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical IMMP trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    New Downtrend Bearish 0.00%
    Bullish Engulfing Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Fell Below 20 DMA Bearish 7.49%
    Older End-of-Day Signals for IMMP ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 10 hours ago
    1.5x Volume Pace about 10 hours ago
    Rose Above Previous Day's High about 10 hours ago
    Rose Above Lower Bollinger Band about 10 hours ago
    Up 3% about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    IMMP Chart by TradingView
    Basic chart:

    Profile

    Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Autoimmune Disease Therapeutic Products

    Is IMMP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 Prima BioMed (IMMP) Loses -34.84% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
    Jun 25 Immutep Signs Exclusive License Agreement with Cardiff University for Next Generation Anti-LAG-3 Molecules for Cancer
    Jun 5 Immutep slips after stock offering
    Jun 5 Immutep successfully completes institutional placement and institutional component of entitlement offer
    Jun 3 Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
    May 29 Immutep's (ASX:IMM) investors will be pleased with their notable 73% return over the last five years
    May 15 Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024
    May 2 Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma
    May 1 Immutep: Realizing The Expected Catalysts, With More To Come
    Apr 29 Immutep Quarterly Activities Report Q3 FY24
    See more IMMP news...

    Comments

    S

    SociableGnat503 11 months ago

    Any thoughts on what to expect here based on the chart? The volume looks quite low here. 

    0 Reply
    T

    TraderMike 11 months ago

    looks range-bound to me

    0 Reply
    S

    SociableGnat503 11 months ago

    What does that mean, short term pain but long term gain? 

    0 Reply
    T

    TraderMike 11 months ago

    It means it's stuck in a range -- going sideways between about 1.9 & 2.4

    0 Reply
    S

    SociableGnat503 10 months ago

    One can hope that it will ultimately pop given the potential and cash runway. 

    0 Reply
    T

    TraderMike 10 months ago

    Hope is not a plan 😁

    0 Reply
    S

    SociableGnat503 10 months ago

    It's why I will never be rich....lol 

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.335
    52 Week Low 1.58
    Average Volume 341,309
    200-Day Moving Average 2.31
    50-Day Moving Average 2.70
    20-Day Moving Average 2.59
    10-Day Moving Average 2.45
    Average True Range 0.24
    RSI (14) 34.64
    ADX 27.05
    +DI 13.68
    -DI 40.99
    Chandelier Exit (Long, 3 ATRs) 2.33
    Chandelier Exit (Short, 3 ATRs) 2.38
    Upper Bollinger Bands 3.16
    Lower Bollinger Band 2.02
    Percent B (%b) -0.01
    BandWidth 43.89
    MACD Line -0.16
    MACD Signal Line -0.08
    MACD Histogram -0.0803
    Fundamentals Value
    Market Cap 238.95 Million
    Num Shares 119 Million
    EPS -0.35
    Price-to-Earnings (P/E) Ratio -5.74
    Price-to-Sales 81.76
    Price-to-Book 3.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.21
    Resistance 3 (R3) 2.21 2.16 2.17
    Resistance 2 (R2) 2.16 2.11 2.15 2.16
    Resistance 1 (R1) 2.08 2.08 2.08 2.08 2.15
    Pivot Point 2.03 2.03 2.02 2.02 2.03
    Support 1 (S1) 1.95 1.98 1.95 1.95 1.87
    Support 2 (S2) 1.90 1.95 1.89 1.86
    Support 3 (S3) 1.82 1.90 1.85
    Support 4 (S4) 1.82